ABOUT THE TRIAL
External links
The Valentines Trial
Patient Enrollment for the Valentines Trial to Continue
Throughout Cardiovascular Research Technologies (CRT) 2010
The first of its kind, the Valentines trial is a multicenter, open-label, one-week registry of up to 300 patients recruited from up to 100 centers around the globe who present with in-stent restenosis (ISR) of a previously placed stent. Results will be presented at CRT 2010. Three principal investigators will chair the trial: Dr. Giuseppe Sangiorgi (Modena, Italy), Prof. Dr. Sigmund Silber (Munich, Germany), and Dr. Pieter R. Stella (Utrecht, Netherlands).
External links
Eurocor GmbH
Eurocor GmbH (Bonn, Germany) will provide the DIORTM drug-eluting balloon for use in the trial and will manage both the trial and its investigators via its own organization and the international distributor network. All data for analysis will be collected via an electronic data capture system and analyzed within the Cardiovascular Research Institute Data Coordinating Center of the Washington Hospital Center.